廣錠
廣錠 Stock: price and insider trades · Taiwan
廣錠: what insiders have been doing
廣錠 has a thin disclosure history in our data (latest filing: 6 October 2020). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 26,288 of 26,911 companies
10.6
score / 100
Value15
Quality6
FCF yld-7.2%
Earn yld-24%
EV/EBITDA·
ROE-26%
Gross mgn-11%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NT$22
Analyst consensus
Income statement
RevenueNT$235.3M
Gross profit-NT$25.7M-11% margin
EBITDA-NT$215.5M-92% margin
Net income-NT$274.9M-194.7% margin
Valuation
P/Book1.3x
Beta0.73
Balance sheet & cash
Market capNT$1.2B
Total debtNT$526.3M
Free Cash Flow-NT$82.9M
Debt / Equity65%
Profitability & ownership
ROE-25.5%
ROA-10.4%
% insiders48.1%
% institutions0.0%
Last declaration on 6 October 2020
Declarations5 total
- 800,000 sharesShareTPExTWMOPS:6441:109/10/06:廖良彬:037t2jo
- 1,100,000 sharesShareTPExTWMOPS:6441:109/09/23:廣積科技股份有限公司:1dwffav
- 1,600,000 sharesShareTPExTWMOPS:6441:109/05/12:廣積科技股份有限公司:0260trk
- 782,560 sharesShareTPExTWMOPS:6441:105/02/01:何志平之配偶:1ffnbii
- 869,714 sharesShareTPExTWMOPS:6441:105/02/01:何志平:0vh59gt
5 of 5 declarations
About 廣錠
廣錠 is a company listed on the XTAI market. It operates in the financial sector, providing various investment-related services.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
